Trial Profile
Phase II Study to Investigate the Efficacy and Safety of BioCart™II in the Treatment of Symptomatic Cartilage Defects of the Femoral Condyle in Comparison With Microfracture
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Autologous cultured chondrocytes (Primary)
- Indications Knee injuries
- Focus Therapeutic Use
- Sponsors ProChon Biotech
- 28 May 2014 New trial record